Annarita Di Lorenzo, PhD

Highlights

61

4 grants

PI
The role of endothelial ceramides in coronary atherosclerosis
National Heart, Lung, and Blood Institute · 2026–2030
R01HL181967-01A1
Co-I
Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaques
National Institute of Neurological Disorders and Stroke · 2022–2027
R01NS123576-01A1
PI
Assessing the combination of Omav, Idebenone, and telmisartan in FA
Friedreich's Ataxia Research Alliance · 2026–2027
FARA 260922-01
PI
Sphingolipid Biology of macrophage in Coronary Atherosclerosis Development and Progression
National Heart, Lung, and Blood Institute · 2021–2025
R01HL152195-04

Completed grants (7)

PI
Effects of Omav, Idebenone, and Telmisartan in the MCK-FXN KO cardiomyopathy mouse model
Friedreich's Ataxia Research Alliance · 2024–2025
FARA 241222-01
Co-I
Ca2+-dependent lipid scrambling and ion transport by TMEM16 proteins
National Institute of General Medical Sciences · 2019–2024
R01GM106717-05A1
PI
Endothelial Sphingolipid Synthesis and Tissue Inflammatory Response
National Heart, Lung, and Blood Institute · 2015–2023· 2 renewals
R01HL126913-08
Co-I
PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy
National Cancer Institute · 2019–2022
R21CA246409-01
PI
A Novel Ischemic Stroke Model Triggered by Endothelial Dysfunction
National Institute of Neurological Disorders and Stroke · 2018–2021
R21NS104512-02
KP
Role of Macrophage-derived Sphingolipids in a Novel Model of Coronary Atherosclerosis
American Heart Association · 2019–2019
19POST34430172
Sub-PI
Mechanisms of Sphingolipid Signaling in Vascular Heath and Disease
National Heart, Lung, and Blood Institute · 2017–2018 · via Boston Children's Hospital (Children's Hospital Corporation)
No publications yet
R01HL135821-02

When Protective Lipids Decline, Health Risks Increase
April 8, 2025
New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression.
Solving the Riddle of the Sphingolipids in Coronary Artery Disease
April 24, 2024
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.